NBTXR-3

Status:: Do Not Prescribe (DNP)
Decision Date:: None

Comments

DNP 6: NICE TA745 - NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal) (Decision date - December 2021)

Black Drug Classifications

6: Have NICE guidance that recommends they should not be used